In the last trading session, 1.11 million shares of the LifeMD Inc (NASDAQ:LFMD) were traded, and its beta was 1.31. Most recently the company’s share price was $5.49, and it changed around -$0.48 or -8.12% from the last close, which brings the market valuation of the company to $218.27M. LFMD currently trades at a discount to its 52-week high of $12.88, offering almost -134.61% off that amount. The share price’s 52-week low was $3.99, which indicates that the current value has risen by an impressive 27.32% since then. We note from LifeMD Inc’s average daily trading volume that its 10-day average is 1.02 million shares, with the 3-month average coming to 526.75K.

LifeMD Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended LFMD as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. LifeMD Inc is expected to report earnings per share of 0.14 for the current quarter.

LifeMD Inc (NASDAQ:LFMD) trade information

Instantly LFMD has showed a red trend with a performance of -8.12% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 7.54 on recent trading dayincreased the stock’s daily price by 27.19%. The company’s shares are currently down -33.84% year-to-date, but still down -6.24% over the last five days. On the other hand, LifeMD Inc (NASDAQ:LFMD) is 19.76% up in the 30-day period. We can see from the shorts that 5.57 million shares have been sold at a short interest cover period of 12.15 day(s).

The consensus price target as assigned by Wall Street analysts is $12, which translates to bulls needing to increase their stock price by 54.25% from its current value. Analyst projections state that LFMD is forecast to be at a low of $12 and a high of $12.

LifeMD Inc (LFMD) estimates and forecasts

LifeMD Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -29.41 percent over the past six months and at a 30.00% annual growth rate that is well above the industry average of 5.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -6.67% in revenue this quarter, and will report an increase of 1,500.00% in the next quarter. The year-over-year growth rate is expected to be 34.59%, up from the previous year.

Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 57.12M in revenue for the current quarter. 7 analysts expect LifeMD Inc to make 58.51M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 44.86M and 44.14M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 27.32%. Forecasts for the next quarter put sales growth at 32.54%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -25.48%.

LFMD Dividends

LifeMD Inc’s next quarterly earnings report is expected to be released in December.

LifeMD Inc (NASDAQ:LFMD)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 15.57% of LifeMD Inc shares, and 40.53% of them are in the hands of institutional investors. The stock currently has a share float of 48.00%. LifeMD Inc stock is held by 136.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 5.9546% of the shares, which is about 2.34 million shares worth $16.03 million.

VANGUARD GROUP INC, with 3.8697% or 1.52 million shares worth $10.42 million as of 2024-06-30, holds the second largest percentage of outstanding shares.